The Top 15 Biotech Companies to Find in Amsterdam
Known for its nightlife and the beauty of its canals, Amsterdam is also the home…
02/09/2021 - 7 minutes
Kiadis Pharma
European Cancer Deals Increasingly Focus on Natural Killer Cells
Natural killer cells are becoming a hot topic in the booming cancer cell therapy scene,…
23/02/2021 - 6 minutes
Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference
Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American…
17/12/2020 - 6 minutes
Kiadis’ Natural Killer Cell Therapies Earn €308M Acquisition by Sanofi
The French big pharma Sanofi has offered €308M to acquire the Dutch firm Kiadis Pharma…
03/11/2020 - 3 minutes
Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal
The Dutch biotech Kiadis Pharma has licensed an off-the-shelf cell therapy program to the pharma…
13/07/2020 - 3 minutes
Mass Layoffs as Dutch Biotech Cancels Phase III Cell Therapy Trial
The Dutch company Kiadis Pharma has discontinued the development of a cell therapy in blood…
13/11/2019 - 2 minutes
Dutch Company Raises €28M to Push Cancer Cell Therapy to European Market
The Dutch Kiadis Pharma has raised €27.6M in a private placement to fund the clinical…
03/06/2019 - 2 minutes
Walking with the Dinosaurs of European Biotech: Which of Them is Roaring the Loudest?
Although biotech may seem like an industry that has only just gotten started, it was…
23/01/2018 - 10 minutes
Dutch Bone Marrow Transplant for Blood Cancer could get rid of Donor Matching
Kiadis Pharma starts Phase III trials with ATIR101, a therapy that could make half-matched donors…
04/12/2017 - 2 minutes
Dutch Biotech Gets Special Designation for Reduced Risk Blood Cancer Treatment
The FDA has backed Kiadis Pharma's lead blood cancer product by granting it the Regenerative Medicine…
20/09/2017 - 2 minutes
Meet the New CEO of the Dutch Biotech Making a Cure for Blood Cancer
Arthur Lahr, CEO of Kiadis Pharma, explains the promising cell therapy the company is developing…
22/05/2017 - 7 minutes
BRIEF: Dutch Biotech Goes for MAA in the EU with new Immunotherapy
Kiadis Pharma has applied for marketing authorization from the EMA for its T cell immune…
26/04/2017 - 1 minute
